The United States Reported Over 400,000 Covid-19 Related Deaths

United States COVID-19 Cases as reported to the Centers for Disease Control and Prevention (CDC) since January 21, 2021.

*Total cases are based on aggregate counts of COVID-19 cases reported by state and territorial jurisdictions to the Centers for Disease Control and Prevention (CDC) since January 21, 2020, with the exception of persons repatriated to the United States from Wuhan, China, and Japan. All displayed counts include confirmed COVID-19 cases and deaths as reported by U.S. states, U.S. territories, New York City (NYC), and the District of Columbia from the previous day. Counts for certain jurisdictions also include probable COVID-19 cases and deaths. Counts for NYC and New York State are shown separately; data for New York state show total cases and deaths for the state excluding data from NYC. COVID-19 case and death data that are not available to CDC, calculates the number of new cases or deaths each day by calculating the difference in cumulative counts reported by the state from the day before. Historical data are not typically updated unless requested by the state. Therefore, the number of historical cases and deaths presented on CDC’s website reflect the date the data was reported to CDC and not necessarily the date the case or death was recorded in the state*

COVID-19 total cases by state

* As of January 21, 2021, Google News reported a new total cases of 24,482,076 in the United States, +3,157,549 new cases (in the last 14 days); and 405,820 deaths.

COVID-19 Vaccines

The World Health Organization (WHO) in partnership with health organizations and pharmaceuticals are working tirelessly to develop effective coronavirus vaccines and treatment. Vaccines work by training and building the body’s immune system to identify and fight off viruses and bacteria. It keeps the body alert to ward off disease-causing germs, preventing illness.

The WHO said there are currently more than 50 COVID-19 vaccine candidates in trials. In the United States, the Food and Drug Administration (FDA) authorized Pfizer and Gilead Sciences for emergency use of their COVID-19 vaccines in authorized healthcare centers. There have been mixed reactions so far, over the effectiveness and prices of these vaccines.

WHO is currently working with scientists, global health organizations, and businesses through the ACT Accelerator to speed up the pandemic response, to develop treatment for the disease.

“When a safe and effective vaccine is found, COVAX (led by WHO, GAVI, and CEPI) will facilitate the equitable access and distribution of these vaccines to protect people in all countries,” WHO published on its website. “People most at risk will be prioritized. While we work towards rolling out a safe and effective vaccine fairly, we must continue the essential public health actions to suppress transmission and reduce mortality.”